DI-070 Indirect comparison of cetuximab vs. panitumumab in metastatic colorectal cancer

B Marmesat; EJ Alegre Del Rey; A Villa; D Guerra; JM Mateo

doi:10.1136/ejhpharm-2015-000639.245

Article info

Drug information and pharmacotherapy

DI-070 Indirect comparison of cetuximab vs. panitumumab in metastatic colorectal cancer

Authors

B Marmesat 1Hospital Punta Europa, Pharmacy, Algeciras, Spain PubMed articles Google scholar articles
EJ Alegre Del Rey 2Hospital Universitario de Puerto Real, Farmacia, Puerto Real, Spain PubMed articles Google scholar articles
A Villa 3Hospital Sas La Linea de La Concepcion, Farmacia, La Linea de La Concepcion, Spain PubMed articles Google scholar articles
D Guerra 4Hospital Punta de Europa, Farmacia, Algeciras, Spain PubMed articles Google scholar articles
JM Mateo 4Hospital Punta de Europa, Farmacia, Algeciras, Spain PubMed articles Google scholar articles

Citation

Marmesat B, Alegre Del Rey E, Villa A, et al

DI-070 Indirect comparison of cetuximab vs. panitumumab in metastatic colorectal cancer

European Journal of Hospital Pharmacy 2015;22:A102.

Publication history

First published March 24, 2015.

Online issue publication

May 13, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password